Editors: Elham Ahmadian, Magali Cucchiarini, Aziz Eftekhari

Nanopharmacology and Nanotoxicology: Clinical Implications and Methods

eBook: US $69 Special Offer (PDF + Printed Copy): US $110
Printed Copy: US $76
Library License: US $276
ISBN: 978-981-5079-70-8 (Print)
ISBN: 978-981-5079-69-2 (Online)
Year of Publication: 2023
DOI: 10.2174/97898150796921230101

Introduction

This book explains key concepts and applications of nanotechnology in clinical medicine and pharmacology. The chapters have been contributed by experts and provide a broad perspective about the current and future developments in pharmacology, toxicology, cell biology, and materials science.

The book is divided into 2 main sections. The first section concerns nanobiotechnology for human health including gastrointestinal disease, kidney diseases, pulmonary disorders, reproductive system, COVID-19, and cancer.

The second section is devoted to toxicological aspects of nanomaterials which involve toxicological assessments of nanotherapeutics and potential solutions for nanotoxicology.

Key Features

- Emphasizes the high degree of interdisciplinary research in pharmacology, toxicology and nanoscience

- Summarizes the results of theoretical, methodological, and practical studies in different medical subspecialties

- Includes special topics such as novel nanotoxicology assessment methods and nano vaccines

- Includes references for further reading

Audience:

Researchers and readers in science, medicine, pharmacology and toxicology

Preface

Nanomedicine is one of the 21st century’s most promising fields and there is rising attention in the world toward the development of new highly specific approaches in the diagnostic and therapeutic applications of nanobiotechnology. This field is a multidisciplinary science and carries the science of incomprehensibly small and portable devices closer to reality.

Among the different applications of nanobiotechnology in health sciences, nanopharmaceuticals, gene therapy, regenerative medicine, targeted drug delivery, and disease diagnostics are the most important. It explores the application of nanotechnology in the development of safe, effective and reliable tools to combat various infections.

Recently, numerous efforts have been made to improve assays for the diagnosis and treatment of diseases including cancer in terms of selectivity and sensitivity based on nanobiotechnology. These developments will increase the survival rate of cancer patients by enabling early detection and treatment. Although only a few nanobotechnology-based assays have been introduced to clinical trials, these methods of cancer diagnosis are poised to move into the clinic in the near future.

The main focus of this book is dedicated to concepts, applications and perspectives regarding combined contributions from pharmaceutical, pharmacological, toxicological, cell biology, and materials science in an attempt to give the reader a feel for the full scope of current and potential future developments. The articles in this volume clearly emphasize the high degree of interdisciplinary research that forms the backbone of this joint venture of Pharmacology/Toxicology and nanoscience.

The book is divided into 2 main sections. The first section concerns nanobiotechnology for human health including gastrointestinal disease, kidney diseases, pulmonary disorders, reproductive system, COVID-19, and cancer.

The second section is devoted to toxicological aspects of nanomaterials which involve toxicological assessments of Nan- therapeutics and potential solutions for nanotoxicology.

We hope that the results of theoretical, methodological, and practical studies presented in the proposed collective work of the authors will be interesting both for specialists and for the general public.

Elham Ahmadian
Kidney Research Center
Tabriz University of Medical Sciences
Tabriz
Iran